Research/Areas of Interest:
nanoelectronics, biosensing, biomaterials, tissue engineering, drug delivery
Education
- Ph.D., Harvard University, USA, 2009
- A.M., Harvard University, Cambridge, United States, 2004
- B.S., Lehigh University, Bethlehem, United States, 2002
Biography
Brian Timko graduated from Lehigh University with B.S. degrees in Chemistry and Chemical Engineering, and from Harvard University with a Ph.D. in Chemistry. He completed his graduate studies in the laboratory of Professor Charles Lieber at Harvard, where he studied semiconductor nanowires and how they could be stably interfaced with living cells and tissue. He completed postdoctoral studies with Professor Robert Langer at MIT and Professor Daniel Kohane at Boston Children's Hospital. During that time, Timko studied nanocomposite materials for cardiac tissue engineering and remotely-triggered drug delivery, and subsequently, he was an instructor in anaesthesiology at Boston Children's Hospital. In 2016, he joined Tufts School of Engineering as an assistant professor in the Department of Biomedical Engineering.
Brian Timko's research interests lie at the intersection of materials science, chemistry, and biology, with a major focus on nanotechnology and nanoscale interfaces between solid-state and biological systems. Central to his laboratory's strategy is the bottom-up paradigm, whereby nanomaterials are synthesized with rationally-controlled electrical, optical, and chemical properties, then assembled into biological systems at physiological conditions. This strategy is leveraged to achieve advances in three interrelated areas: nanoelectronics for biosensing, nanocomposites for tissue engineering, and externally-triggered drug delivery systems.
Brian Timko's research interests lie at the intersection of materials science, chemistry, and biology, with a major focus on nanotechnology and nanoscale interfaces between solid-state and biological systems. Central to his laboratory's strategy is the bottom-up paradigm, whereby nanomaterials are synthesized with rationally-controlled electrical, optical, and chemical properties, then assembled into biological systems at physiological conditions. This strategy is leveraged to achieve advances in three interrelated areas: nanoelectronics for biosensing, nanocomposites for tissue engineering, and externally-triggered drug delivery systems.